Hillsdale Investment Management »

BioCryst Pharmaceuticals shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3M 562k 7.59
2025-06-30 $4.8M 536k 8.96
2025-03-31 $3.9M 522k 7.50
2024-12-31 $4.1M 542k 7.52
2024-09-30 $6.3k 830 7.60
2020-06-30 $820k 172k 4.77